Release of shares from escrow
Released
Released
Announcement PDF
WHERE BIOTECHNOLOGY & NANOTECHNOLGY MEET
ASX Announcement
23 January 2018
Release of shares from escrow
MELBOURNE — 23 January 2018 — In accordance with Listing Rule 3.10A, Imagion Biosystems Limited
(the Company) advises that 30,950,569 fully paid ordinary shares in the Company, which are unquoted
and subject to escrow restrictions imposed by ASX in accordance with Appendix 9B of the ASX Listing
Rules, will be released from escrow on 7 February 2018.
In accordance with ASX Listing Rule 2.8.2, the Company will apply for quotation of the shares under an
Appendix 3B within 10 business days after the end of the escrow period.
-Ends
About Imagion Biosystems
Imagion Biosystems is at the crossroads of biotechnology and nanotechnology. Its novel bioimaging and
nanomagnetic detection systems have been developed specifically to detect cancer and other diseases earlier
and with higher specificity than is currently possible. With MagSense TM technology, the company has the
potential to optimise patient care and reduce mortality rates across various cancer indications. Based in
Albuquerque, New Mexico, Imagion Biosystems listed on the Australian Securities Exchange (ASX) in June
2017.
For further information please contact:
info@imagionbio.com or corpsecretary@imagionbio.com
U.S. Media Contact:
Matthew Wygant
matthew@biotechwriting.com
+1-408-905-7630
Australian Media & Investor Relations:
Matt Wright, NWR Communications
matt@nwrcommunications.com.au
+61-451-896-420
Imagion Biosystems Limited
ACN 616 305 027
Level 8, 555 Bourke Street, Melbourne VIC 3000
www.imagionbiosystems.com
Share your feedback
Discover